PerkinElmer is uniquely positioned to bring innovative preclinical imaging capabilities to help scientists transform data into informed decisions that accelerate research.  Our in vivo imaging capabilities cover a wide range of applications in many fields of research and include multiple modalities such as: PET, Optical, MicroCT and X-ray standalone and integrated systems. In addition to our flagship IVIS® platform for 2D and 3D optical imaging, our imaging portfolio includes PET and microCT modalities including the G8 PET/CT system offering high sensitivity in a benchtop format and the Quantum GX microCT which combines high-speed, low-dose, high-resolution in one system. In addition to our state-of-the-art imaging platforms, PerkinElmer has a large portfolio of optical and radioimaging reagents to support your preclinical research in oncology, cardiovascular, infectious disease and other disease areas.